Therefore, the understanding of crosstalk between Raf/MAPK/ERK1/2 and PI3K/AKT signal pathways during brain ischemia/reperfusion may eventually lead to the development of new therapeutic strategy for the disease. Here, AKT1 is linked to brain ischemia.